Pfizer Releases New Data From Maternal RSV Vaccine Trials

Pfizer has released new data from its trials for a potential maternal vaccine against the common respiratory virus RSV that shows an 81 percent effectiveness against severe illness in the first 90 days of a newborn’s life. NBC News medical contributor Dr. Kavita Patel has the details. 

» Subscribe to NBC News:
» Watch more NBC video:

NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features,,, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

Connect with NBC News Online!
NBC News App:
Breaking News Alerts:
Visit NBCNews.Com:
Find NBC News on Facebook:
Follow NBC News on Twitter:

#Pfizer #Covid19 #RSV

You May Also Like